Core Laboratories NV (CLB) stands as a leading provider of specialized reservoir optimization services and products in the oil and gas industry, focusing on enhancing reservoir characterization and maximizing production efficiency. Leveraging advanced technologies and proprietary analytical methods, the company delivers innovative solutions that prioritize sustainability and environmental responsibility. With a strong global presence, Core Labs is strategically positioned to seize new growth opportunities and effectively navigate the challenges of an evolving energy landscape, making it a compelling choice for institutional investors seeking long-term value in the sector.
| Revenue (TTM) | $524.73M |
| Gross Profit (TTM) | $104.54M |
| EBITDA | $60.57M |
| Operating Margin | 1.62% |
| Return on Equity | 11.10% |
| Return on Assets | 4.86% |
| Revenue/Share (TTM) | $11.35 |
| Book Value | $5.84 |
| Price-to-Book | 1.97 |
| Price-to-Sales (TTM) | 0.98 |
| EV/Revenue | 1.283 |
| EV/EBITDA | 9.81 |
| Quarterly Earnings Growth (YoY) | -31.60% |
| Quarterly Revenue Growth (YoY) | -1.40% |
| Shares Outstanding | $46.10M |
| Float | $45.42M |
| % Insiders | 1.43% |
| % Institutions | 112.28% |
Volatility is currently expanding
HOUSTON, June 30, 2026 /PRNewswire/ -- Core Laboratories (NYSE: "CLB") will host its second quarter 2026 conference call for investors and analysts at 7:30 a.m. CDT / 8:30 a.m.
CLB faces persistent geopolitical uncertainty, weaker laboratory activity, cost inflation and delayed shipments, limiting visibility into a stronger recovery.
Core Laboratories (CLB) reported earnings 30 days ago. What's next for the stock?
Investors need to pay close attention to CLB stock based on the movements in the options market lately.
CLB's Q1 earnings meet estimates but fall Y/Y as a revenue miss and Middle East disruptions weigh on both key segments.
Core Laboratories Inc. (CLB) Q1 2026 Earnings Call Transcript
REVENUE OF $121.8 MILLION, DOWN 12% SEQUENTIALLY AND FLAT YEAR-OVER-YEAR OPERATING INCOME OF $1.9 MILLION; EX-ITEMS, $6.6 MILLION, DOWN 58% SEQUENTIALLY AND 44% YEAR-OVER-YEAR GAAP LOSS PER SHARE OF $0.02 ; EPS EX-ITEMS OF $0.06, DOWN 72% SEQUENTIALLY AND 58% YEAR-OVER-YEAR FREE CASH FLOW OF $0.5 MILLION NET DEBT INCREASED BY $3.9 MILLION; LEVERAGE RATIO AT 1.20 COMPANY REPURCHASED 51,781 SHARES OF COMMON STOCK, FOR $0.9 MILLION AGGREGATE PURCHASE PRICE COMPANY ANNOUNCES Q2 2026 QUARTERLY DIVIDEND HOUSTON, April 29, 2026 /PRNewswire/ -- Core Laboratories Inc. (NYSE: "CLB") ("Core," "Core Lab," or the "Company") reported first quarter 2026 revenue of $121,800,000. Core's operating income was $1,900,000, with a loss per diluted share of $0.02, all in accordance with U.S. generally accepted accounting principles ("GAAP").
Investors interested in Oil and Gas - Field Services stocks are likely familiar with Drilling Tools International Corp. (DTI) and Core Laboratories (CLB). But which of these two stocks presents investors with the better value opportunity right now?
CLB heads into Q1 earnings with lowered guidance, geopolitical disruptions and cost pressures raising concerns over a potential earnings miss.
Core Laboratories (CLB) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
